Earnings Feed
Start Free
OSIRIS THERAPEUTICS, INC.·4

May 29, 4:30 PM ET

OSIRIS THERAPEUTICS, INC. 4

4 · OSIRIS THERAPEUTICS, INC. · Filed May 29, 2015

Insider Transaction Report

Form 4
Period: 2015-05-27
OSIRIS THERAPEUTICS, INC.OSIR
JACOBY PHILIP R JR
Vice President of Finance
Transactions
  • Exercise/Conversion

    Common Stock

    2015-05-27$6.46/sh+3,751$24,231→ 27,640 total
  • Exercise/Conversion

    Common Stock

    2015-05-27$7.74/sh+11,389$88,151→ 23,889 total
  • Exercise/Conversion

    Common Stock

    2015-05-27$7.13/sh+4,860$34,652→ 32,500 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2015-05-27$7.74/sh−11,389$88,151→ 67,792 total
    Exercise: $7.74From: 2013-03-12Exp: 2020-03-12→ Common Stock (11,389 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2015-05-27$7.13/sh−4,860$34,652→ 59,181 total
    Exercise: $7.13From: 2013-02-14Exp: 2021-02-14→ Common Stock (4,860 underlying)
  • Sale

    Common Stock

    2015-05-27$18.55/sh−20,000$371,080→ 12,500 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2015-05-27$6.46/sh−3,751$24,231→ 64,041 total
    Exercise: $6.46From: 2013-05-27Exp: 2020-05-27→ Common Stock (3,751 underlying)

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -